logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
10/04/2026
Herriot CEO: As long as the situation in the Middle East remains stable, we currently anticipate that there will not be a domino effect on trade in other regions.
Latest
4 m ago
Yuexiu Capital: It is expected that the net profit for the first quarter of 2026 will be between 12.47 billion and 13.79 billion yuan, a year-on-year increase of 90% to 110%.
5 m ago
Shanghai Stock Exchange: The limit on the price fluctuation of main board warning-listed stocks will be adjusted from 5% to 10%.
6 m ago
Liu Niu Mountain: In March 2026, the sales revenue of live pigs was 102 million yuan, an increase of 27.25% compared to the previous month, and a decrease of 6.36% compared to the same period last year.
6 m ago
Jincheng Pharmaceuticals: Subsidiary received certificate of registration for injectable erythromycin lactobionate drug.
7 m ago
Rongchang Biotechnology: The indication for the use of vedolizumab as first-line treatment for HER2-expressing urothelial carcinoma has been approved.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.